Therapeutic Applications of Umbilical Cord Stem Cells in the Treatment of Human Diseases

Umbilical cord stem cells (UCSCs) have garnered significant attention in regenerative medicine due to their unique biological properties, including high proliferative capacity, low immunogenicity, and multipotency. Derived from cord blood and Wharton’s jelly, these cells— primarily mesenchymal and hematopoietic stem cells—have demonstrated therapeutic potential across a wide range of diseases.[1].This review explores the clinical and experimental applications of UCSCs in treating hematological disorders, neurodegenerative diseases, cardiovascular conditions, autoimmune diseases, and liver and lung injuries.[2][3][4] Numerous clinical trials have shown encouraging outcomes, highlighting the regenerative and Immunomodulatory roles of UCSCs. Despite certain limitations such as scalability and long-term safety concerns, UCSCs remain a promising and ethically favorable option in the evolving landscape of stem cell-based therapies. Umbilical cord stem cells (UCSCs) represent a dynamic and increasingly utilized cell source in regenerative medicine, offering promising therapeutic outcomes for a variety of chronic, degenerative, and immune-mediated diseases.[2].